Guest Editorial: Warning Letters ? A Symptom?

by Steven S. Kuwahara, Titan Pharmaceuticals Numerous warning letters and consent decrees have revealed problems in coping with even simple parts of the GMPs.

Related Content:

Inside Washington: Biotech Manufacturing ? Obstacle or Opportunity?

The Importance of Freezing on Lyophilization Cycle Development

Outsourcing Outlook: Using Earned-Value Analysis for Better Project Management